ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on a Phase II Study of Hyper-CVAD With Sequential Blina +/- Inotuzumab Ozogamicin in Adults With Newly Diagnosed B-Cell ALL
By
ASCO 2022 Conference Coverage
FEATURING
Nicholas Short
By
ASCO 2022 Conference Coverage
FEATURING
Nicholas Short
25 views
June 15, 2022
Comments 0
Login to view comments.
Click here to Login
Leukemia